Skip to content

TRV GP V, LLC

Reporting owner on Forms 3, 4 and 5, CIK 1990717.

TRV GP V, LLC reported on 1 issuer in 9 filings, the latest a 13F-HR filed 2026-11-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
RAPP · Rapport Therapeutics, Inc.CIK 2012593director, 10% owner12026-11-03

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
RAPP · Rapport Therapeutics, Inc.Common Stock2026-10-30A granted+238,095$216,518,620Form 4
RAPP · Rapport Therapeutics, Inc.Common Stock2026-10-30A granted+1,190,476$212,159,694Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13F-HR 0001193125-26-463550 Quarter ended 2026-09-302026-11-16
Form 4 0001193125-26-445438 Rapport Therapeutics, Inc.2026-11-03
13F-HR 0001193125-26-340725 Quarter ended 2026-06-302026-08-10acceptance time not in the bulk data set
13F-HR 0001193125-26-212010 Quarter ended 2026-03-312026-05-07acceptance time not in the bulk data set
13F-HR 0001193125-26-051785 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001193125-25-280200 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0000950123-25-007373 Quarter ended 2025-06-302025-08-08acceptance time not in the bulk data set
13F-HR 0000950123-25-004485 Quarter ended 2025-03-312025-05-09acceptance time not in the bulk data set
13F-HR 0000950123-25-002037 Quarter ended 2024-12-312025-02-13acceptance time not in the bulk data set